UNVCOTCHealthcare · Drug Manufacturers - Specialty & Generic

Univec, Inc.

$0.00-2.27%($-0.00)

TickerSpark Score

44/100

Weak

Valuation

Profitability

100

Growth

Health

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a UNVC research report →

52-Week Range13% of range

Low $0.00

Current $0.00

High $0.01

Companywww.univec.com

Univec, Inc. , through its subsidiaries, produces, licenses, and markets medical products in the United States and internationally. It primarily provides auto-disable and safety syringes.

CEO: David Dalton
IPO: 1997
Employees: 3
HQ: Owings Mills, MD, US

Price Chart

-25.86% · this period

Valuation

Market Cap: $5.42M
P/E: -4.47
P/S: 61.63
P/B: -0.30
EV/EBITDA: -5.44
Div Yield: 0.00%

Profitability

Gross Margin: 13.66%
Op Margin: -1441.94%
Net Margin: -1377.32%
ROE: 6.94%
ROIC: 7.67%

Growth & Income

Revenue: $85.01K · 130.97%
Net Income: $-1,215,374 · 1.85%
EPS: $0.00 · 200.00%
Op Income: $-1,203,115
FCF YoY: -28175.02%

Performance & Tape

52W High: $0.01
52W Low: $0.00
50D MA: $0.00
200D MA: $0.00
Beta: 1.10
Avg Volume: 1.31M

Get TickerSpark's AI analysis on UNVC

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime